Literature DB >> 12606893

Why is parity protective for uterine fibroids?

Donna Day Baird1, David B Dunson.   

Abstract

Uterine fibroids are benign tumors, the etiology of which is not understood. Symptoms can be debilitating, and the primary treatment is surgery, usually hysterectomy. Epidemiologic data show that pregnancy is associated with reduced risk of fibroids. We hypothesize that this association is attributable to a protective effect of postpartum involution of the uterus. After each pregnancy the uterus rapidly returns to prepregnancy size by dramatic remodeling of the tissue. We hypothesize that small fibroids are eliminated during this process. We present preliminary epidemiologic evidence that is consistent with this hypothesis. If the hypothesis is supported by more direct evidence, it may have broader implications, supporting the idea that tissue remodeling may be a general mechanism for limiting tumor development.

Entities:  

Mesh:

Year:  2003        PMID: 12606893     DOI: 10.1097/01.EDE.0000054360.61254.27

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  73 in total

1.  Pregnancy-related fibroid reduction.

Authors:  Shannon K Laughlin; Amy H Herring; David A Savitz; Andrew F Olshan; Julia R Fielding; Katherine E Hartmann; Donna D Baird
Journal:  Fertil Steril       Date:  2010-05-07       Impact factor: 7.329

2.  Self-report versus ultrasound measurement of uterine fibroid status.

Authors:  Sharon L Myers; Donna Day Baird; Andrew F Olshan; Amy H Herring; Jane C Schroeder; Leena A Nylander-French; Katherine E Hartmann
Journal:  J Womens Health (Larchmt)       Date:  2011-11-01       Impact factor: 2.681

3.  1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model.

Authors:  Sunil K Halder; Chakradhari Sharan; Ayman Al-Hendy
Journal:  Biol Reprod       Date:  2012-04-19       Impact factor: 4.285

Review 4.  A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays.

Authors:  Phyllis C Leppert; William H Catherino; James H Segars
Journal:  Am J Obstet Gynecol       Date:  2006-04-25       Impact factor: 8.661

5.  1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells.

Authors:  Sunil K Halder; J Shawn Goodwin; Ayman Al-Hendy
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

6.  Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.

Authors:  Laveta Stewart; Gladys M Glenn; Pamela Stratton; Alisa M Goldstein; Maria J Merino; Margaret A Tucker; W Marston Linehan; Jorge R Toro
Journal:  Arch Dermatol       Date:  2008-12

7.  Expanding upon the Human Myometrial Stem Cell Hypothesis and the Role of Race, Hormones, Age, and Parity in a Profibroid Environment.

Authors:  Lauren E Prusinski Fernung; Kimya Jones; Aymara Mas; Daniel Kleven; Jennifer L Waller; Ayman Al-Hendy
Journal:  Am J Pathol       Date:  2018-08-01       Impact factor: 4.307

8.  Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18-30 years old): a pilot study.

Authors:  Erica E Marsh; Geraldine E Ekpo; Eden R Cardozo; Maureen Brocks; Tanaka Dune; Leeber S Cohen
Journal:  Fertil Steril       Date:  2013-03-15       Impact factor: 7.329

9.  Vitamin d and the risk of uterine fibroids.

Authors:  Donna Day Baird; Michael C Hill; Joel M Schectman; Bruce W Hollis
Journal:  Epidemiology       Date:  2013-05       Impact factor: 4.822

10.  Evaluating risk factors for differences in fibroid size and number using a large electronic health record population.

Authors:  Michael J Bray; Eric S Torstenson; Sarah H Jones; Todd L Edwards; Digna R Velez Edwards
Journal:  Maturitas       Date:  2018-05-11       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.